Global orphan dermatology products market to beat $6B by 2024

The global orphan and rare dermatology premium products market is expected to grow rapidly from $1.64 billion in 2017 to...

September 3, 2018 | Monday | News
Sartorius sets up Life Science Factory for startup entrepreneurs

With its newly founded, independent Life Science Factory, Sartorius, a leading international partner of the biopharmaceu...

August 31, 2018 | Friday | News
TB Alliance Launches Clinical Trial for New TB drug

TB Alliance, a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight...

August 31, 2018 | Friday | News
Roche to create industry-ready graduates

Roche Diagnostics and the University of Indianapolis are partnering to create a custom talent pipeline for biomedical eq...

August 30, 2018 | Thursday | News
SOTIO acquires Cytune Pharma

SOTIO, a biotechnology company owned by the PPF Group, announces today the completion of the acquisition of Cytune Pharm...

August 30, 2018 | Thursday | News
ImaginAb, CPDC enter into an agreement

ImaginAb, Inc., an immuno-oncology imaging company, and Centre for Probe Development and Commercialization (CPDC), a Can...

August 30, 2018 | Thursday | News
Are you Ready for EU FMD? Urgency, Consistency and Planning are Key

Singapore - In February 2019, the Delegated Regulation to the Falsified Medicines Directive (FMD) comes legally into for...

August 29, 2018 | Wednesday | News
CytoDyn signs definitive agreement to acquire Prostagene

Singapore – CytoDyn, a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple th...

August 28, 2018 | Tuesday | News
Urovant licenses novel gene therapy for overactive bladder

Singapore - Urovant Sciences, a clinical-stage biopharmaceutical company focused on developing therapies for urologic co...

August 28, 2018 | Tuesday | News
Patrys, Walter and Eliza Hall awarded grant

Singapore - Patrys Limited and the Walter and Eliza Hall Institute of Medical Research have recently been awarded a...

August 28, 2018 | Tuesday | News
Eisai announces long-term cardiovascular outcomes data for anti-obesity Agent

Eisai Inc. recently announced that results from the CAMELLIA-TIMI 61 cardiovascular (CV) outcomes trial in patients trea...

August 28, 2018 | Tuesday | News
Study reveals reasons of death after non-cardiac surgery

The main reasons why people die after non-cardiac surgery are revealed in a study of more than 40,000 patients from six ...

August 28, 2018 | Tuesday | News
Researchers find new blood clot prevention strategy

Feinstein Institute for Medical Research Professor Alex C. Spyropoulos, MD, has uncovered an anticoagulant treatment str...

August 27, 2018 | Monday | News
BHF launches £30 M funding for cardiovascular research

The British Heart Foundation (BHF) has launched the Big Beat Challenge, a unique research funding award that will bring ...

August 27, 2018 | Monday | News
Shire receives USFDA nod for TAKHZYRO

Shire, the leading global biotechnology company focused on rare diseases, has announced that following priority review, ...

August 27, 2018 | Monday | News
GT Biopharma appoints David Cardino as VP, Finance

GT Biopharma Inc. (GTBP) an immuno-oncology biotechnology company focused on innovative treatments based on the company'...

August 24, 2018 | Friday | News
Facebook, NYU to initiate fastMRI using AI

Facebook has partnered with New York University (NYU) School of Medicine to initiate a research project focused on lever...

August 24, 2018 | Friday | News
FDA approves first drug for neurotrophic keratitis

Singapore- The U.S. Food and Drug Administration approved the first drug, Oxervate (cenegermin), for the treatment of ne...

August 23, 2018 | Thursday | News